XML 55 R34.htm IDEA: XBRL DOCUMENT v3.23.2

EARNINGS PER SHARE (Tables)

6 Months Ended

Jun. 30, 2023

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Earnings Per Share

The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):

			Three Months Ended June 30,												Six Months Ended June 30,
			2023						2022						2023						2022
Basic:
Net income attributable to Edwards Lifesciences Corporation			$	307.1					$	406.4					$	647.6					$	780.0
Weighted-average shares outstanding			606.9						620.9						607.2						621.5
Basic earnings per share			$	0.51					$	0.65					$	1.07					$	1.26
Diluted:
Net income attributable to Edwards Lifesciences Corporation			$	307.1					$	406.4					$	647.6					$	780.0
Weighted-average shares outstanding			606.9						620.9						607.2						621.5
Dilutive effect of stock plans			3.4						5.8						3.4						6.6
Dilutive weighted-average shares outstanding			610.3						626.7						610.6						628.1
Diluted earnings per share			$	0.50					$	0.65					$	1.06					$	1.24

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration